Delivery Order SPE2DB22D2211-SPE2DB25FRYZE
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$53K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $13,006.45 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA). The $91,954.04 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2025 with a completion date of May 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,282.65 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 20, 2024, with a completion date of August 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,126.01 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024 with a completion date of November 25, 2024. The contract is a Delivery Order off of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support...
This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XELJANZ XR 11 MG TABLET. The contract, valued at $6,534.85, is a firm fixed price award issued by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through June 11, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,534.14 and is a firm fixed-price delivery order with an ultimate completion date of December 12, 2024. This contract is not designated as a set-aside and is part of...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,969.33 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4566199195 XELJANZ XR 11 MG TABLET UU 30S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,446.74 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 24, 2024, with an ultimate completion date of October 25, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, involves the delivery of XELJANZ XR 11 MG TABLET medication to the Defense Logistics Agency (DLA). The $6,563.94 firm-fixed-price contract, with an ultimate completion date of April 30, 2024, is issued as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a comprehensive...
This federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,056.60 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 9, 2024, with a completion date of December 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...